Pancreatic Cancer Research

Clinical trialObservationalCompleted

Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System

Outcome After Pancreatectomy for Neuroendocrine Tumor and Evaluation of the WHO 2017 Grading System: a Retrospective Multicentric Analysis of 138 Consecutive Patients.

Outcome
Finished, no results posted
Phase
Observational
Status
Completed
Study type
Observational
Start
1 January 1997
Ended
1 February 2019
Enrollment
138 participants
Sites
1
Primary outcomes
Disease-free survival at 5 years
Sponsor type
Academic / other
Results posted
No
Last update
18 April 2019

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in pancreatic neuroendocrine tumor (PanNET) patients. Methods: Data collected between 1997 and December 2017 were analyzed. Histological grading and staging was based on the WHO 2017 grading system. Outcome after surgery and predictors of overall survival (OS) and disease free survival (DFS) were evaluated.